抗凝血酶

口服华法令抗凝中蛋白C和抗凝血酶Ⅲ的变化

Changes in Protein C and Antithrombin ⅲ during Warfarin Anticoagulation

库存全血抗凝血酶Ⅲ及蛋白C变化的研究

Changes in Antithrombin - ⅲ and Protein-C in Stored Blood

急性肺损伤血管性血友病因子、抗凝血酶-Ⅲ和蛋白质C的变化

Changes of von Willebrand factor , anti-thrombin - ⅲ and protein C in acute lung injury

糖尿病患者血浆抗凝血酶Ⅲ及蛋白C活性水平的初步探讨

The preliminary study of the activity of plasma antithrombin ⅲ and protein C in diabetes patients

系统性红斑狼疮患者蛋白C系统及抗凝血酶Ⅲ变化的研究

Study on Changes in Protein C System and Antithrombin ⅲ in Patients with Systemic Lupus Erythematosus

肝硬化和糖尿病病人血浆蛋白C和抗凝血酶Ⅲ的测定

The Comparative Observation of Plasma Protein C and Antithrombin ⅲ Levels in Hepatic Cirrhosis and Diabetes Mellitus

目的利用DNA改组技术大幅度提高抗凝血酶Ⅲ（AT-Ⅲ）的生物活性。

Objective To improve the bioactivity of antithrombin ⅲ( AT - ⅲ) significantly by DNA shuffling .

中晚期胎儿抗凝血酶和蛋白C活性的检测

Measurement of levels of antithrombin and protein C in healthy human fetus from middle to late time of gestation

抗凝血酶III，纤溶酶原及D-二聚体的研究及临床意义

Study and Clinical Significance of antithrombin ⅲ , Plasminogen and D-Dimer

结论：失血性休克可导致大鼠内皮细胞损伤，抗凝血酶和蛋白C呈消耗性下降；

Conclusion : The rats with hemorrhagic shock have trauma of endothelial cells and decrease of protein C and antithrombin due to consumption .

抗凝血酶III，绵羊抗兔；石蜡切片。

Antithrombin III , Sheep anti-Rabbit ; paraffin .

利凡诺去白蛋白人血浆再利用的实验研究Ⅱ.抗凝血酶Ⅲ和蛋白C抑制物的纯化与鉴定

Laboratory study on reproducibility of no albumin human plasma by rivanol precipitation ⅱ . Purification and identification of antithrombin ⅲ and protein C inhibitor

研究人员将抗凝血酶III上的肝素结合肽段黏附在称为聚乙二醇的人工合成材料上。

The researchers attached heparin-binding peptides from antithrombin III to a synthetic material called polyethylene glycol .

从人血浆和人尿中纯化了蛋白C系统各组分及抗凝血酶Ⅲ。

The procedures for isolation and purification of PC , PS , PCI and antithrombin III ( ATIII ) from human plasma and TM from human urine were developed .

水蛭素可抑制ICH后的脑水肿形成，抗凝血酶治疗可能成为ICH后脑水肿的一种可行治疗方法。

Hirudin could inhibit the formation of cerebral edema after ICH .

抗凝血酶Ⅲ（AT-Ⅲ）在CHO细胞表达

Expression of Recombinant Human Antithrombin ⅲ ( AT - ⅲ ) in CHO Cells

本文报道急性脑梗塞和急性脑出血各30例患者的血浆蛋白C活性（PC：A）及抗凝血酶Ⅲ活性（ATⅢ：C）测定。

Protein C ( PC ) and antithrombin ⅲ ( AT - ⅲ ) were measured in 30 patients with cerebral infarction , 30 with cerebral hemorrhage , and 30 normal subjects .

目的探讨抗凝血酶活性（AT：A）检测在诊断弥散性血管内凝血（DIC）中的意义。

Objective To investigate the diagnostic significance of detection of antithrombin activity in DIC .

目的探讨抗凝血酶-Ⅲ（AT-Ⅲ）对内毒素血症大鼠凝血功能异常的治疗作用。方法采用静脉注射革兰阴性菌脂多糖（LPS）复制大鼠内毒素血症凝血功能异常模型。

Objective To study the treatment effects of antithrombin - ⅲ( AT - ⅲ) on coagulation abnormalities in rats with endotoxaemia .

重组水蛭素血浆水平依其抗凝血酶活性（TT延长）予以测定。

The rH ( plasma ) level was measured ex vivo by antithrombin activity with TT prolongation as index .

目的探讨不同程度的肝硬化患者血浆凝血因子Ⅱ活性（FⅡ∶C）与抗凝血酶活性（AT∶A）的变化及其临床意义。

Objective To investigate the variation and clinical significance of the serum Factor ⅱ( F ⅱ∶ C ) and antithrombin ( AT ∶ A ) activity in the patients with hepatocirrhosis .

目的：建立人抗凝血酶Ⅲ（ATⅢ）的ELISA检测试剂盒及ATⅢ的纯化提供试剂准备。

Objective : To develop ELISA reagent kit for detection of human antithrombin ⅲ( AT ⅲ) and to make reagent preparations for purification of AT ⅲ .

目的观察患者回到ICU后的抗凝血酶活性以及术后各种不良结果的联系。

AIM To investigate the association between antithrombin activity at admission to the ICU ( ICU-antithrombin activity ) and various outcome variables .

实验性颈动脉粥样硬化模型中血栓素B2和6-酮-前列腺素F1α与抗凝血酶Ⅲ和纤溶酶原活性的改变

The Changes of Thromboxane B2 , 6-ket-prostaglandin F1 α, Antithrombin ⅲ and Plasminogen in a Experimental Carotid Atherosclerotic Model of Rabbits

新生儿窒息的凝血功能及抗凝血酶ⅢVWFD-二聚体测定及其临床意义

Detection and clinical significance of coagulation function , serum AT - ⅲ, VWF , D-D in newborns with asphyxia

目的探讨急性脑梗死溶栓治疗前后血中凝血酶原片段1+2（F1+2）、凝血酶抗凝血酶复合物（TAT）和D二聚体（DD）的动态变化及临床意义。

Objective To explore the dynamic data of F1 + 2 and TAT and D-dimer during the thrombolysis treatment with Urokinase .

急性时相蛋白：抗凝血酶Ⅲ、血浆纤连蛋白、前白蛋白和白蛋白在文昌鱼中的组织定位以及LPS处理后浓度的变化

Acute Phase Proteins : Antithrombin ⅲ, Plasma Fibronectin , Transthyretin and Albumin , Their Locations in Amphioxus and the Changes of Their Concentrations after Treatment with LPS

人抗凝血酶Ⅲ的cDNA克隆、表达、纯化及其重组蛋白对DIC大鼠模型的疗效研究

The Research of the cDNA Clone , Expression & Purification of Human Antithrombin ⅲ and the Therapeutic Effect of Its Recombinant Protein on DIC Rat Model

研究者利用了肝素（一种多糖）和血液中的抗凝血酶III（一种多肽片断）之间的相互作用来控制凝固时间。

Researchers have used the interaction between a polysaccharide called heparin and a peptide fragment of a protein called antithrombin III , which is contained in the bloodstream to control clotting .

结果：经过DNA改组和噬菌体亲和筛选，成功获得抗凝血酶活性提高的水蛭素变异体HV2-N47K。

RESULTS : After shuffling and selection , a clone ( HV2-N47K ) with high antithrombotic activity was obtained .